A blinded, randomized clinical trial evaluating the efficacy and safety of lokivetmab compared to ciclosporin in client-owned dogs with atopic dermatitis-Reference-Cited by-同舟云学术

A blinded, randomized clinical trial evaluating the efficacy and safety of lokivetmab compared to ciclosporin in client-owned dogs with atopic dermatitis

Published:2017-09-14 Issue:6 Volume:28 Page:593-e145
ISSN:0959-4493
Container-title:Veterinary Dermatology
language:en
Short-container-title:Vet Dermatol

Author:

Moyaert Hilde¹^ORCID,Van Brussel Leen¹,Borowski Stasia¹,Escalada Monica¹,Mahabir Sean P.²,Walters Rodney R.²,Stegemann Michael R.¹

Affiliation:

1. VMRD; Zoetis Belgium SA; Mercuriusstraat 20 Zaventem 1930 Belgium

2. VMRD; Zoetis Inc.; 333 Portage Street Kalamazoo MI 49007 USA

Funder

Zoetis Inc, Parsipanny, NJ, USA

Publisher

Wiley

Subject

General Veterinary

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/vde.12478/fullpdf

Reference40 articles.

1. Atopic Dermatitis

2. The ACVD task force on canine atopic dermatitis (XIV): clinical manifestations of canine atopic dermatitis;Griffin;Vet Immunol Immunopathol,2001

3. Evidence-based veterinary dermatology: a systematic review of the pharmacotherapy of canine atopic dermatitis;Olivry;Vet Dermatol,2003

4. Atopica Summary of Product Characteristics Elanco Europe Ltd Basingstoke, Hampshire, UK 2016 http://www.vmd.defra.gov.uk/ProductInformationDatabase/SPC_Documents/SPC_328729.doc

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of Allogeneic and Xenogeneic Exosomes for the Treatment of Canine Atopic Dermatitis: A Pilot Study;Animals;2024-01-16

2. Expansion of platform physiologically-based pharmacokinetic model for monoclonal antibodies towards different preclinical species: cats, sheep, and dogs;Journal of Pharmacokinetics and Pharmacodynamics;2023-11-10

3. A prospective, randomized, double-blind, placebo-controlled multisite, parallel-group field study in dogs with osteoarthritis conducted in the United States of America evaluating bedinvetmab, a canine anti-nerve growth factor monoclonal antibody;Veterinary Anaesthesia and Analgesia;2023-09

4. Long term use of Cytopoint® in atopic dogs;2023-08-17

5. Evaluation of the clinical efficiencyof lokivetmab in client privately ownedatopic dogs – multicenter study;Polish Journal of Veterinary Sciences;2023-07-26